SITC 2026 has ended. This guide stays up as the record of who was there. Next: SITC 2027, Nov 3–7, 2027 in National Harbor

AstraZeneca at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

AstraZeneca brings 6 presentations to SITC 2026 in Phoenix, and exhibits at Booth 801. Its program centres on bispecific antibodies and armored CAR T cells, along with regulatory and industry-collaboration topics for biotech. One concrete item walks through its rilvegostomig bispecific program from the lab bench onward.

OrganizationSITC 2026 Attendance
AstraZeneca
Cambridge, United Kingdom
Large pharma
Global biopharmaceutical company that discovers, develops and sells prescription medicines, with oncology among its main therapy areas.
Booth
Exhibiting at Booth 801
Fri, Nov 610:00am–2:00pm · 5:00pm–7:00pmSat, Nov 710:00am–2:00pm · 6:00pm–8:10pm
Workshop
Wed Nov 4
2:00pm–5:00pm
Biotech Regulatory Roundtable
  1. 2:00pm–2:10pmOpening Remarks: SITC Biotech Initiative: A Quest for 100 Novel Agents
  2. 2:10pm–2:55pmPanel Discussion 1: Conversations with FDA Oncology Leaders on Hot Topics
  3. 2:55pm–3:10pmNetworking Break
  4. 3:10pm–3:55pmPanel Discussion 2: Biomarker Discovery and Digital AI
  5. 3:55pm–4:10pmNetworking Break #2
  6. 4:10pm–4:55pmPanel Discussion 3: Regulatory Framework for New IO Agents
  7. 4:55pm–5:00pmClosing Remarks
Session
Thu Nov 5
12:00pm–1:30pm
Poster
Sat Nov 7
12–1:30pm
6:40–8:10pm

Explore the full SITC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full SITC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at AstraZeneca

Tell us what you sell and we’ll find the people at AstraZeneca most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction